Risks of long-term vision loss after trabeculectomy identified

Article

Risk factors for long-term vision loss after trabeculectomy included preoperative split fixation on visual fields

Risk factors for long-term vision loss after trabeculectomy included preoperative split fixation on visual fields, according to a study published in the Archives of Ophthalmology.

The study led by Dr Brian A. Francis, Department of Ophthalmology, Doheny Eye Institute, Los Angeles, California, USA, investigated the medical records of 301 eyes in 262 patients who underwent trabeculectomy between January 1999 and September 2003. Mild or moderate postoperative vision loss was categorized by a decrease in Snellen acuity of 3 – 5 lines. Permanent postoperative vision loss was identified if visual acuity did not return to 3 lines within the 6-month follow up period.

Of the 301 eyes studied, 24 suffered from permanent vision loss, 13 presented with mild or moderate vision loss and 11 experienced severe vision loss. Permanent mild or moderate vision loss in 10 eyes and permanent severe vision loss 6 eyes had no identifiable cause.

Transient vision loss was experienced in 170 eyes. This consisted of 79 eyes with mild or moderate vision loss and 91 eyes with severe vision loss. The mean recovery times were 88 days and 78 days, respectively.

The risk factors identified in the study included preoperative split fixation on visual fields, preoperative number of quadrants with split fixation, and postoperative choroidal effusions with eventual resolution.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.